Cellular Therapy Nurse Experts as a Conduit Between Hospital Clinical, Business Operations, and Revenue Cycle Teams

Area of Science:

• Oncology
• Hematology
• Cell and Gene Therapy

Background:

• Genetically modified cellular therapies (GMCTs) are vital for life-threatening illnesses.
• GMCTs present significant barriers to patient access and healthcare delivery due to high costs, specialized care needs, and limited treatment centers.

Purpose of the Study:

• To examine logistic and financial clearance challenges of GMCTs.
• To highlight the role of nurses in facilitating patient access and therapy delivery.

Main Methods:

• Descriptive overview of financial and operational considerations for GMCT administration.
• Focus on reimbursement processes, access barriers, and nursing contributions to financial clearance.

Main Results:

• High costs, specialized care, and limited availability of GMCTs create complex logistic and reimbursement challenges.
• These challenges can delay treatment access and threaten therapy delivery sustainability.
• Nurses are critical in supporting financial clearance, streamlining access, and optimizing reimbursement.

Conclusions:

• Addressing logistic and financial challenges is essential for equitable GMCT access.
• Nurses play a pivotal role in navigating complex reimbursement landscapes and ensuring therapy delivery.
• Interdisciplinary collaboration is key to overcoming barriers in cell and gene therapy delivery.